This book represents identification and targeting critical disease signaling pathways in male breast cancer (MBC) towards development of phytochemical-based personalized medicine. The book contains 12 sections where first 3 sections deal with details such as MBC-epidemiology, risk factors, screening and diagnosis, treatment options etc. From sections 4 to 10, rationale of the work and identification of MBC disease signaling pathways, drug targets, targeting phyto-chemicals, and personalized treatment strategies have been described and the results have been concluded in section 11. Section 12 has listed all relevant references used in this work. This is the first of its kind of work towards development of personalized phytochemical-based treatment strategy for MBC. It is a part of D. Barh's PhD work and authors hope that, the strategy will be useful in developing personalized chemo-prevention and phyto-therapy in MBC and will minimize the side effects that are prevalent while using breast cancer specific chemotherapy.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
This book represents identification and targeting critical disease signaling pathways in male breast cancer (MBC) towards development of phytochemical-based personalized medicine. The book contains 12 sections where first 3 sections deal with details such as MBC-epidemiology, risk factors, screening and diagnosis, treatment options etc. From sections 4 to 10, rationale of the work and identification of MBC disease signaling pathways, drug targets, targeting phyto-chemicals, and personalized treatment strategies have been described and the results have been concluded in section 11. Section 12 has listed all relevant references used in this work. This is the first of its kind of work towards development of personalized phytochemical-based treatment strategy for MBC. It is a part of D. Barh's PhD work and authors hope that, the strategy will be useful in developing personalized chemo-prevention and phyto-therapy in MBC and will minimize the side effects that are prevalent while using breast cancer specific chemotherapy.
D. BARH (MSc, MTech, MPhil, PhD, PGDM) is a scientist, consultant biotechnologist & business analyst. He is a pioneer researcher in MBC & cardiac myxoma cell signaling & drug targets and is the founder & PI of IIOAB. K. DAS (MSc, PhD) is Prof. in Genetics, AIS and H.C. SRIVASTAVA (MSc, PhD) is Ex. Principal Scientist in medicinal plant, IIHR.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book represents identification and targeting critical disease signaling pathways in male breast cancer (MBC) towards development of phytochemical-based personalized medicine. The book contains 12 sections where first 3 sections deal with details such as MBC-epidemiology, risk factors, screening and diagnosis, treatment options etc. From sections 4 to 10, rationale of the work and identification of MBC disease signaling pathways, drug targets, targeting phyto-chemicals, and personalized treatment strategies have been described and the results have been concluded in section 11. Section 12 has listed all relevant references used in this work. This is the first of its kind of work towards development of personalized phytochemical-based treatment strategy for MBC. It is a part of D. Barh's PhD work and authors hope that, the strategy will be useful in developing personalized chemo-prevention and phyto-therapy in MBC and will minimize the side effects that are prevalent while using breast cancer specific chemotherapy. 92 pp. Englisch. N° de réf. du vendeur 9783843367592
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Barh DebmalyaD. BARH (MSc, MTech, MPhil, PhD, PGDM) is a scientist, consultant biotechnologist & business analyst. He is a pioneer researcher in MBC & cardiac myxoma cell signaling & drug targets and is the founder & PI of IIOAB. K. . N° de réf. du vendeur 5466694
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book represents identification and targeting critical disease signaling pathways in male breast cancer (MBC) towards development of phytochemical-based personalized medicine. The book contains 12 sections where first 3 sections deal with details such as MBC-epidemiology, risk factors, screening and diagnosis, treatment options etc. From sections 4 to 10, rationale of the work and identification of MBC disease signaling pathways, drug targets, targeting phyto-chemicals, and personalized treatment strategies have been described and the results have been concluded in section 11. Section 12 has listed all relevant references used in this work. This is the first of its kind of work towards development of personalized phytochemical-based treatment strategy for MBC. It is a part of D. Barh''s PhD work and authors hope that, the strategy will be useful in developing personalized chemo-prevention and phyto-therapy in MBC and will minimize the side effects that are prevalent while using breast cancer specific chemotherapy.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 92 pp. Englisch. N° de réf. du vendeur 9783843367592
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book represents identification and targeting critical disease signaling pathways in male breast cancer (MBC) towards development of phytochemical-based personalized medicine. The book contains 12 sections where first 3 sections deal with details such as MBC-epidemiology, risk factors, screening and diagnosis, treatment options etc. From sections 4 to 10, rationale of the work and identification of MBC disease signaling pathways, drug targets, targeting phyto-chemicals, and personalized treatment strategies have been described and the results have been concluded in section 11. Section 12 has listed all relevant references used in this work. This is the first of its kind of work towards development of personalized phytochemical-based treatment strategy for MBC. It is a part of D. Barh's PhD work and authors hope that, the strategy will be useful in developing personalized chemo-prevention and phyto-therapy in MBC and will minimize the side effects that are prevalent while using breast cancer specific chemotherapy. N° de réf. du vendeur 9783843367592
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Male Breast Cancer | Identifying and targeting critical disease signaling pathways towards development of personalized phytotherapy | Debmalya Barh (u. a.) | Taschenbuch | 92 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783843367592 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 107227567
Quantité disponible : 5 disponible(s)